Just released: How to raise venture capital in 2023

Download

The Hidden 409A Compliance Trap: Why Your $10M Series A Might Make Employee Options Worthless

TL:DR

Key Takeaways

Carl Niedbala
Carl Niedbala

Managing Partner; COO & Co-Founder

Working for a startup has major incentives, subject to the evolving dynamics of the industry: growing alongside a promising startup, helping build the company culture, making your way into the tech industry, and more. Other especially alluring benefits include an employee stock option (ESO), which is a non-qualified deferred compensation plan that provides additional payment options. This way, workers are motivated to help the company thrive, as their benefits will grow with it too, but it might come with a substantial risk.

With this in mind, a successful Series A will sound like a victory for everyone in a startup—financial goals have been met to satisfy leadership, employees, and the board of directors.

But it isn’t that simple. A high-flying round can create a hidden, disastrous risk in skyrocketing stock options that employees are now locked into and can’t afford.

This is where an independent appraisal under Section 409A valuation comes in handy, helping companies tick more than just a compliance box—while mitigating any substantial risk involved. An objective 409A valuation, from a risk management perspective, supports startups’ efforts to offer their employees attainable benefits, thereby improving acquisition and retention. Let’s explore why.

The Valuation Jump Horror Story

From the moment their team begins to grow, many privately-held companies start offering ESO to become an attractive workplace for top talent, from engineers to marketers, designers, and more. At first, stock options are easy to handle and a tax-free gain that won’t be part of gross income, but as the company valuation increases, the story changes dramatically.

Let’s illustrate this case with a pre-seed startup valued at $2.5 million. Initially, ESOs are priced around $0.25 per share, an affordable and exclusive benefit—which might include stock appreciation rights—that motivates employees. The company quickly progresses and hits a key product milestone that secures them a competitive Series A round that closes at a headline-grabbing $15 million post-money valuation.

This new valuation is undoubtedly great news for everyone in the company, as their efforts have materialized into a fundraiser round that will give them more freedom to improve their product and take it to market.

However, there’s a catch. The company’s new post-money valuation means its 409A valuation also shifts, spiking to a chilling $8.50 per share; a 3,400% increase.

Needless to say, the ESO becomes an unattainable perk and deferred compensation for employees—a junior engineer with 10,000 options now faces an exercise cost of $85,000. Although the money is technically there on paper (“in the money”), it is financially out of reach.

EBOOK

De-Risk the Fundraising Journey

Understanding the Section 409A Compliance Lag

To understand what went wrong, it’s crucial to lay the groundwork for what a 409A valuation really is. This is a formal, third-party assessment of the fair market value (FMV) of a company’s common stock, required under Section 409A of the Internal Revenue Code, which governs deferred compensation plans at private companies (this differs significantly from the implications of offering stocks from publicly-traded companies). It involves figures like company valuation and a FMV discount since the stock isn’t public yet.

So, while a startup valuation is negotiated based on future projections and investor demand, the 409A valuation needs to be justified with more tangible facts, that is, historical data, with regulators like the Internal Revenue Service.

This creates a lag mechanism of sorts that correctly appraises the 409A valuation while a startup’s performance takes time to catch up to its new given valuation. As a result, the 409A immediately jumps after a fundraising round, while the company slowly grasps its new worth.

Unfortunately, this is hardly a bug in the system, but rather a feature designed to prevent founders from issuing “cheap” options before a major funding event (triggered by the Enron debacle in 2002, which forever changed the established securities market).

Non-compliance with an independent 409A valuation can result in severe penalties, with all deferred compensation immediately counted as gross income for the taxable year. When done well, companies achieve safe harbor status and maintain ownership or effective control that allows them to issue their stocks tax-free at the objective valuation given.

The Psychological and Financial Impact on Your Team

Proper 409A compliance works so that employees can get the real picture of their ESO before, during, and after a fundraising event. Otherwise, leadership might offer them a strike price that’s too good to be true, leaving them with a jump in strike price (or exercise price) that will make them feel like the goalposts have been moved—this is no benefit at all, especially when stock options become unexpectedly costly.

The main goal of a nonqualified deferred compensation plan is to create a long-term incentive for employees while the company complies with the Internal Revenue Code law. Once this option becomes inaccessible to them, the incentive is destroyed, and with it, a strong employee retention strategy.

As such, key employees might prefer to look elsewhere with more tangible equity. This will also hurt company culture with lower morale and leadership trust, as those who decide to stay will see founders as out of touch or even deceitful people.

Proactive Solutions to Mitigate the Risk

Avoiding a surge in stock strike price begins with weighing the factors that affect this figure. To start, founders can use a pre-fundraising modeling tool that takes variables like valuation ranges, fundraising amounts, and runway assumptions to assess the potential impact on the 409A valuation after a fundraising round.

This way, startups can sensibly plan their next financing rounds and comply with the law, taking into account the shift in 409A valuation and the special rules associated with it. Ultimately, it won’t be an unpleasant surprise for founders or an uncomfortable spike for employees.

The Strategic Risk Management Approach

There are effective solutions to meet 409A compliance so that startup leaders don’t have to cross their fingers and hope for the best. For instance, let’s go back to the pre-seed company that was later valued at $15 million and offer the following options:

  • Stock splits: This option helps make the jump more manageable for employees. A 1-for-10 split can reduce the per-share price from $8.50 to $0.85, making it an affordable option once again while being compliant and keeping reasonable benefits as a talent retention strategy.
  • Option repricing: This dynamic involves repricing the strike price of certain ESOs so it adjusts to the new price, either to be “in the money” or “at the money.” However, this should be seen as a last resort, as it involves legally binding and complex rules and requires investor approval.
  • Proper timing: Expert guidance can make all the difference in managing the gap between 409A valuation and startup valuation, suggesting that timing is a major asset in controlling these shifts. For example, timing the 409A valuation with a funding event can sometimes help avoid massive spikes in strike price.

Going From Deferred Compensation Liability to Asset

From an insurance and risk management perspective, founders shouldn’t let a successful fundraising round become a future liability due to a lack of proactive measures to plan the 409A valuation they must comply with.

Acting with 409A compliance in mind will further inform financial decision-making so that startups can grow sustainably, from their leadership to the smallest link in the chain.

Hiring top talent is a key winning factor in this growth, counting on outstanding employees who stay motivated by the perks of ESO and performance-based compensation alongside other strategic solutions, such as supplemental executive retirement plans, despite the fast-paced environment of a startup.

Knowing about the potential trap of Section 409A compliance will prepare founders to successfully deliver excellent benefits to their employees based on company value and future performance—ensuring their non-qualified deferred compensation truly serves its purpose as a powerful, shared long-term incentive for all preceding taxable years.

360 Risk Assessment

Understand how your insurance coverage & risk management measures up.

Related Articles

Startup Valuation 1
October 1 • Growth

Database vs. Guesswork: Why Your Startup Valuation Is Probably Wrong (And How to Fix It)

Optimize your startup valuation for funding success and investor confidence with our accurate, data-backed approach.

biotech startups
September 24 • Growth

Beyond the Hype: How Biotech Startups Manage Risk for Real-World Drug Development

How biotech startups are overcoming challenges and achieving breakthroughs with savvy strategies, partnerships, and risk management.

biotech venture capital
September 17 • Growth

Navigating Biotech Venture Capital: Trends and Insights for Founders

In a challenging funding environment, securing biotech venture capital requires more than great science. Learn how to align your pitch with top VC firms, build a resilient team, and manage risks to attract the right partners and propel your clinical-stage company forward.

startup valuation
September 3 • Growth

Beyond the Hype: A Comprehensive Guide to Startup Valuation

Master startup valuation beyond the bubble. Learn why risk management, insurance, and sustainable growth are now key for a successful, resilient business.

post money valuation formula
August 21 • Growth

Unlocking Startup Value: The Post-Money Valuation Formula Explained

Learn the crucial post-money valuation formula and why it’s a key metric for startups. Understand its impact on founder equity and investor returns, and how to avoid common pitfalls.

digital health funding
August 13 • Growth

Digital Health Funding: A Guide to Risk Management for Every Startup

Securing digital health funding demands robust risk management. Learn how to navigate unique sector challenges, from data privacy to regulatory compliance, and attract investors.